14th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 2000

Jan. 29 - Feb. 5, 2000
Marilleva, Trento, Italy

S-109

Reveal® Plus: a new tool for monitoring arrhythmia

N. Bottoni, L. Rapallini*, C. Menozzi on behalf of the Reveal Plus Clinical Investigators**.
S. Maria Nuova Hospital, Reggio Emilia, Italy, *Medtronic, Inc., **see Appendix

Background

Syncope often remains unexplained despite a complete diagnostic evaluation, because of its infrequent and unpredictable nature^1-3. The conventional investigations include short-term ECG monitoring as ECG, Holter, external loop recorder and provocative tests such as head-up tilt test and electrophysiological study. Short term ECG monitoring has a low sensitivity and the provocative tests have a low or unknown predictive value.

The experience with the implantable loop recorder (ILR) demonstrates its effectiveness in clinical practice. Despite the good diagnostic yield (65-88%) of the Reveal ILR, 14% of the patients with symptoms were unable to correctly activate the device⁴.